Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.013
▾0.00 (0.00%)
Last trade: 20/10, 11:41PM
Market cap
$2.17m
20 min delay
Talk to Hexima Ltd directly.
Sign up to their Investor Hub for direct access to the Hexima Ltd team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Hexima Limited (Hexima) is an Australia-based biotechnology company. The Company is engaged in the research and development of plant-derived defensin peptides for applications as human therapeutics. Its lead product candidate, HXP124 applied in a topical formulation, is a potential new prescription treatment for toenail fungal infections (or onychomycosis). The Company is conducting a 132 patient Australian phase IIb clinical trial of HXP124 for onychomycosis. The Company holds granted, long-life patents protecting HXP124 in markets globally.
Website
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.013
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets